Bienville Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,502
Closed -$277K 97
2019
Q2
$277K Sell
1,502
-16
-1% -$2.87K 0.03% 155
2019
Q1
$288K Sell
1,518
-116
-7% -$22.2K 0.03% 136
2018
Q4
$318K Buy
+1,634
New +$319K 0.06% 108
2018
Q1
Sell
-2,134
Closed -$371K 144
2017
Q4
$371K Buy
2,134
+148
+7% +$26.2K 0.06% 120
2017
Q3
$370K Sell
1,986
-251
-11% -$44.5K 0.06% 101
2017
Q2
$385K Hold
2,237
0.11% 95
2017
Q1
$367K Buy
+2,237
New +$372K 0.09% 91
2016
Q4
Sell
-1,756
Closed -$293K 156
2016
Q3
$293K Buy
1,756
+78
+5% +$13.2K 0.07% 102
2016
Q2
$255K Buy
+1,678
New +$261K 0.07% 90

Other funds holding AMGN

Bienville Capital Management's AMGN Position: Q3 2019 in Review

Bienville Capital Management sold out of Amgen (AMGN) in Q3 2019, closing a stake of 1,502 shares — an estimated $277K sold.

Bienville Capital Management first reported a position in AMGN in Q2 2016 and held it in 9 quarters. The position peaked at $385K in Q2 2017. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Bienville Capital Management reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Bienville Capital Management sold 1,502 Amgen shares in Q3 2019, an estimated $277K.
  • Bienville Capital Management first reported a position in Amgen in Q2 2016 and held it in 9 quarters.
  • Bienville Capital Management's Amgen position peaked at $385K in Q2 2017.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Bienville Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.